Nevro Corp. (NYSE:NVRO) Q3 2023 Earnings Call Transcript

David Turkaly: And one quick follow-up on the GLP. It sounds like you literally said that you expect zero impact and that I think I heard that, and that many of your patients in the trial were already on it. I mean, is that like half or could you just provide like a percent there? And did I hear that correctly?

Kevin Thornal: Yes. So, yes, I will provide. It is about a third, a little less than a third of the patients in the PDN study were already on GLP-1s, or the class of drugs. And so, they obviously have been on those for years. I mean, it is not a new drug. So they have been on those for years and they still met the inclusion criteria that meant they had painful diabetic neuropathy despite taking those drugs. So, that is what gives us the confidence. And then, I will reiterate in the prepared remarks as well, I mean, we are very in the very, very early innings. We are probably still in batting practice in the full launch of PDN with two million to three million patients. And obviously, you can do the math. I mean, we are very, very little penetration.

So see, even if a big portion of that market happened to go away. We were still well within our ability to grow for a really long period of time. But the confidence is not only, the patients who are already in our PDN study that still had the benefit and had great results. But also, we obviously talked with some of the top leading endocrinologists in the world that are part of our KOL, key opinion leader group. And so we take the guidance from them as well because they are the experts to see the patients every day.

Operator: The next question is from Rich Newitter with Truist. Your line is open. Okay. It appears that there are no further questions. I will turn it back to the presenters for any closing remarks.

Kevin Thornal: Alright. Thank you, operator. Appreciate it. And thanks everyone for joining us today, and I look forward to reporting on our progress on our next call. Talk to everyone soon. Thank you.

Operator: Ladies and gentlemen, this concludes today’s conference call. Thank you for participation. You may now disconnect.